Advertisement
Screener

Panbela Therapeutics, Inc. Shareholders' Equity

Panbela Therapeutics, Inc. Shareholders' Equity

Panbela Therapeutics, Inc. had Shareholders' Equity of -$18.17 million as of 2024-09-30, per its 10-Q filed 2024-11-14.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:StockholdersEquity · last filed 2024-11-14

  • 2024-09-30: Stockholders' Equity Attributable to Parent -$18.17M.
  • 2024-06-30: Stockholders' Equity Attributable to Parent -$10.57M; Stockholders' Equity Attributable to Parent as first filed -$10.57M.
  • 2024-03-31: Stockholders' Equity Attributable to Parent -$3.19M; Stockholders' Equity Attributable to Parent as first filed -$3.19M.
  • 2023-12-31: Stockholders' Equity Attributable to Parent -$4.71M.
Period endStockholders' Equity Attributable to ParentStockholders' Equity Attributable to Parent as first filed
2024-09-30-$18.17M
10-Q · filed 2024-11-14
2024-06-30-$10.57M
10-Q · filed 2024-11-14
-$10.57M
10-Q · filed 2024-08-13
2024-03-31-$3.19M
10-Q · filed 2024-11-14
-$3.19M
10-Q · filed 2024-05-15
2023-12-31-$4.71M
10-Q · filed 2024-11-14
2023-09-30-$2.48M
10-Q · filed 2024-11-14
2023-06-30$4.79M
10-Q · filed 2024-11-14
$4.80M
10-Q · filed 2023-08-10
2023-03-31$2.54M
10-Q · filed 2024-11-14
2022-12-31-$8.05M
10-Q · filed 2024-11-14
2022-09-30-$8.28M
10-Q · filed 2023-11-09
-$8.28M
10-Q · filed 2022-11-10
2022-06-30-$4.84M
10-Q · filed 2023-11-09
2022-03-31$6.58M
10-Q · filed 2023-11-09
$6.58M
10-Q · filed 2022-05-12
2021-12-31$10.21M
10-Q · filed 2023-11-09
$10.21M
10-K · filed 2022-03-24
2021-09-30$13.46M
10-Q · filed 2022-11-10
2021-06-30$5.89M
10-Q · filed 2022-11-10
$5.90M
10-Q · filed 2021-08-11
2021-03-31$7.58M
10-Q · filed 2022-11-10
2020-12-31$8.45M
10-K · filed 2023-03-16
$8.45M
10-K · filed 2021-03-25
2020-09-30$9.55M
10-Q · filed 2021-11-10
2020-06-30$1.60M
10-Q · filed 2021-11-10
2020-03-31$724.00K
10-Q · filed 2021-11-10
2019-12-31$1.38M
10-K · filed 2022-03-24
$1.39M
10-K · filed 2020-03-24
2019-09-30$2.39M
10-Q · filed 2020-11-12
2019-06-30-$117.00K
10-Q · filed 2020-11-12
2019-03-31-$588.00K
10-Q · filed 2020-11-12
2018-12-31$268.00K
10-K · filed 2021-03-25
2018-09-30-$542.00K
10-Q · filed 2019-11-13
2018-06-30$110.00K
10-Q · filed 2019-11-13
2018-03-31-$2.32M
10-Q · filed 2019-11-13
2017-12-31-$3.69M
10-K · filed 2020-03-24
2017-09-30-$2.10M
10-Q · filed 2017-11-14
2017-06-30-$955.00K
10-Q · filed 2017-08-10
2017-03-31$338.00K
10-Q · filed 2017-05-11
2016-12-31-$4.64M
10-K · filed 2019-03-22
2016-09-30-$3.50M
10-Q · filed 2016-11-10
2016-06-30-$2.64M
10-Q · filed 2016-08-11
2016-03-31-$3.50M
10-Q · filed 2016-05-12
2015-12-31-$2.68M
10-K · filed 2018-03-21
2015-09-30-$1.99M
10-Q · filed 2015-11-16
2015-06-30-$372.10K
10-Q · filed 2015-08-13
2015-03-31-$290.31K
10-Q · filed 2015-05-15
2014-12-31-$1.32M
10-K · filed 2017-03-30
-$210.96K
10-K · filed 2015-03-30
2014-09-30-$375.99K
10-Q · filed 2014-11-14
2014-06-30-$288.78K
10-Q · filed 2014-08-14
2014-03-31-$239.96K
10-Q · filed 2014-05-15
2013-12-31$1.41M
10-K · filed 2016-03-08
-$137.89K
10-K · filed 2014-03-28
2013-09-30-$126.71K
10-Q · filed 2013-11-14
2013-06-30-$91.29K
10-Q · filed 2013-08-14
2013-03-31-$86.11K
10-Q · filed 2013-05-15
2012-12-31-$40.85K
10-K · filed 2015-03-30
2011-12-31-$404.99K
10-K · filed 2014-03-28
2010-12-31-$437.18K
10-K · filed 2013-03-26